Decitabine is a potent antineoplastic agent classified as a hypomethylating agent and nucleoside analogue, primarily indicated for the treatment of myelodysplastic syndromes and acute myeloid leukemia.… Read more














































Decitabine is a potent antineoplastic agent classified as a hypomethylating agent and nucleoside analogue, primarily indicated for the treatment of myelodysplastic syndromes and acute myeloid leukemia. This drug functions by inhibiting DNA methyltransferase, a mechanism that induces DNA hypomethylation and promotes the reactivation of genes involved in cell differentiation and apoptosis. To support rigorous pharmaceutical quality control, this category provides a comprehensive selection of Decitabine reference standards. These include critical impurities, degradation products, and stable isotope labelled compounds essential for precise analytical testing. Laboratories rely on these materials for robust method development, stability studies, and detailed impurity profiling to ensure compliance with regulatory safety guidelines. By utilizing these structurally characterized standards, researchers can achieve accurate identification and quantification during routine quality control procedures, maintaining the highest standards for the analytical assessment and evaluation of the drug substance.